Despite a drug crystallisation issue pushing back its testing timeline, Phosphagenics continues to offer upside through its drug patch delivery technology in the view of Bell Potter.
Weekly update on recommendation, target price, and earnings forecast changes.
The Chartist suggests the road of least resistance for Telstra shares might be south. He’s awaiting for technical support to kick in.
This week’s Tweets on Twitter by Your Editor.
Chris Gray of the Switzer Super Report provides some guidelines for property investing within a self-managed super fund.
Market analysts at FXCM demonstrate how to determine the direction of a market’s trend.
A glance through the latest expert views and predictions about commodities with Barclays Capital updating forecasts, Citi reiterating oil price estimates and reviews of aluminium, bulks and gold.
A review of McMillan Shakespeare’s profit result leaves Goldman Sachs expecting solid earnings growth in coming years.
We share a response from the FNArena Editor to a subscriber question about what is happening at retailer JB Hi-Fi.
Global growth is slowing – especially in advanced-technology economies. Regardless of cyclical trends, long term economic growth may grind to a halt.
